(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics DNA Probes/Biochips >  Future Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)

Future Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)



 

For Table of Contents, List of Tables and Sample Pages, email [email protected] or call +1 212 564 2838.

This report provides the following data:

  • Geographic Coverage:
    -          France
    -          Germany
    -          Italy
    -          Japan
    -          Spain
    -          UK
    -          USA
  • Five-year sales forecasts for:
    -          Infectious Diseases
    -          Cancer
    -          Forensic Testing
    -          Genetic Diseases
    -          Paternity Testing/HLA Typing, and other applications.
  • Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
  • Sales and market shares for major suppliers of molecular diagnostics and NAT assays.


To order sections of this report, contact Client Services


     
   
Local PDF: $4750.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X